PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Cardiovascular·MeSH: Arrhythmogenic Right Ventricular Dysplasia
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| rp-a601 | Rocket Pharmaceuticals Inc. (RCKT) |
Frequently asked questions
How many drugs are in development for PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)?
BioSniper tracks 1 drug in development for PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) across 1 company.
How many clinical trials target PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)?
There are 1 clinical trial targeting PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) tracked by BioSniper.
Deep-dive into PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis